Breaking News

Lubrizol Supports Women’s Health Worldwide

Awarded grant for generic contraceptive injection research to advance women’s health around the globe.

By: Contract Pharma

Contract Pharma Staff

The Lubrizol Corp.’s contract development and manufacturing organization (CDMO) Lubrizol Life Science Health (LLS Health), has been awarded a grant to support its research on injectable contraceptive formulations designed to bring accessible contraceptive products to women in developing nations.   Around 220 million women in developing countries lack access to contraceptives and voluntary family planning information and services.1 It is hoped that through funding from the Bill & Meli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters